Literature DB >> 25912054

Effects of nitric oxide and its congeners on sickle red blood cell deformability.

Andrea M Belanger1, Christian Keggi1, Tamir Kanias2,3, Mark T Gladwin2,3, Daniel B Kim-Shapiro1,4.   

Abstract

BACKGROUND: Sickle cell disease (SCD) is characterized by hemoglobin polymerization upon deoxygenation. Polymerization causes the sickle cells to become rigid and misshapen (sickling). Red blood cell (RBC) dehydration greatly increases polymerization. Cycles of sickling and unsickling cause an influx of calcium that leads to loss of potassium via the calcium-activated Gardos channel, which dehydrates the cells leading to increased polymerization. In this study the effects of nitric oxide (NO) and its congeners on RBC deformability were examined, focusing on sickle RBCs (sRBCs). STUDY DESIGN AND METHODS: RBCs from patients with SCD and from nonpatients were exposed to various compounds that release NO or its congeners. Intracellular calcium was increased using a calcium ionophore or cycling of oxygen tension for sRBCs. Deformability was measured by laser-assisted osmotic gradient ektacytometry.
RESULTS: Consistent with a previous report, sodium nitroprusside (SNP) was found to protect against calcium-induced loss of deformability in normal RBCs, but (contrary to some previous reports) no effect of any NO donors was observed when calcium influx was not induced. Importantly, in studies of deoxygenation-induced dehydration of sRBCs, SNP resulted in substantial improvements in deformability (p = 0.036) and hydration (p = 0.024). Sodium nitrite showed similar trends. SNP was shown to have no effect on calcium influx, but reduced potassium efflux.
CONCLUSION: These data suggest that SNP and perhaps certain nitrogen oxides (like nitrite) inhibit the Gardos channel and may be able to protect sickle cells from dehydration and thereby improve outcome in the disease.
© 2015 AABB.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25912054      PMCID: PMC4605849          DOI: 10.1111/trf.13134

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  23 in total

1.  Red blood cells express a functional endothelial nitric oxide synthase.

Authors:  Petra Kleinbongard; Rainer Schulz; Tienush Rassaf; Thomas Lauer; André Dejam; Thomas Jax; Intan Kumara; Putrika Gharini; Svetlana Kabanova; Burcin Ozüyaman; Hans-Georg Schnürch; Axel Gödecke; Artur-A Weber; Mirko Robenek; Horst Robenek; Wilhelm Bloch; Peter Rösen; Malte Kelm
Journal:  Blood       Date:  2005-12-20       Impact factor: 22.113

Review 2.  Sodium nitroprusside: twenty years and counting.

Authors:  J A Friederich; J F Butterworth
Journal:  Anesth Analg       Date:  1995-07       Impact factor: 5.108

3.  Increased levels of endothelin-1 in plasma of sickle cell anemia patients.

Authors:  A C Rybicki; L J Benjamin
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113

4.  Ca2+ permeability in deoxygenated sickle cells.

Authors:  M D Rhoda; M Apovo; Y Beuzard; F Giraud
Journal:  Blood       Date:  1990-06-15       Impact factor: 22.113

Review 5.  Pathogenesis and treatment of sickle cell disease.

Authors:  H F Bunn
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

Review 6.  The potential role of the red blood cell in nitrite-dependent regulation of blood flow.

Authors:  Rakesh P Patel; Neil Hogg; Daniel B Kim-Shapiro
Journal:  Cardiovasc Res       Date:  2010-10-14       Impact factor: 10.787

Review 7.  The intermediate-conductance Ca2+ -activated K+ channel (KCa3.1) in vascular disease.

Authors:  D L Tharp; D K Bowles
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2009-01

8.  Novel inhibitors of the Gardos channel for the treatment of sickle cell disease.

Authors:  Grant A McNaughton-Smith; J Ford Burns; Jonathan W Stocker; Gregory C Rigdon; Christopher Creech; Susan Arrington; Tara Shelton; Lucia de Franceschi
Journal:  J Med Chem       Date:  2008-01-31       Impact factor: 7.446

9.  The involvement of the Ca-dependent K channel and of the KCl co-transport in sickle cell dehydration during cyclic deoxygenation.

Authors:  M Apovo; Y Beuzard; F Galacteros; D Bachir; F Giraud
Journal:  Biochim Biophys Acta       Date:  1994-02-22

10.  Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis.

Authors:  E Graido-Gonzalez; J C Doherty; E W Bergreen; G Organ; M Telfer; M A McMillen
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113

View more
  14 in total

Review 1.  Modulation of Local and Systemic Heterocellular Communication by Mechanical Forces: A Role of Endothelial Nitric Oxide Synthase.

Authors:  Ralf Erkens; Tatsiana Suvorava; Christian M Kramer; Lukas D Diederich; Malte Kelm; Miriam M Cortese-Krott
Journal:  Antioxid Redox Signal       Date:  2017-02-16       Impact factor: 8.401

Review 2.  Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia.

Authors:  Viktoria Kuhn; Lukas Diederich; T C Stevenson Keller; Christian M Kramer; Wiebke Lückstädt; Christina Panknin; Tatsiana Suvorava; Brant E Isakson; Malte Kelm; Miriam M Cortese-Krott
Journal:  Antioxid Redox Signal       Date:  2017-01-18       Impact factor: 8.401

Review 3.  Cellular microdomains for nitric oxide signaling in endothelium and red blood cells.

Authors:  Francesca Leo; Beate Hutzler; Claire A Ruddiman; Brant E Isakson; Miriam M Cortese-Krott
Journal:  Nitric Oxide       Date:  2020-01-03       Impact factor: 4.427

4.  Red blood cell mechanical sensitivity improves in patients with sickle cell disease undergoing chronic transfusion after prolonged, subhemolytic shear exposure.

Authors:  Michael J Simmonds; Silvie Suriany; Derek Ponce; Jon A Detterich
Journal:  Transfusion       Date:  2018-10-16       Impact factor: 3.157

5.  Development of Zinc Chelating Resin Polymer Beads for the Removal of Cell-Free Hemoglobin.

Authors:  Kelli Simms; Elisabeth Rebholz; Robert M Mayberry; Swati Basu; Andreas Perlegas; Martin Guthold; Daniel B Kim-Shapiro; Elaheh Rahbar
Journal:  Ann Biomed Eng       Date:  2019-03-27       Impact factor: 3.934

6.  Nitric oxide pathology and therapeutics in sickle cell disease.

Authors:  Daniel B Kim-Shapiro; Mark T Gladwin
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

Review 7.  Erythrocytes and Vascular Function: Oxygen and Nitric Oxide.

Authors:  Christine C Helms; Mark T Gladwin; Daniel B Kim-Shapiro
Journal:  Front Physiol       Date:  2018-02-22       Impact factor: 4.566

8.  Comparative study of sickle cell anemia and hemoglobin SC disease: clinical characterization, laboratory biomarkers and genetic profiles.

Authors:  Milena Magalhães Aleluia; Teresa Cristina Cardoso Fonseca; Regiana Quinto Souza; Fábia Idalina Neves; Caroline Conceição da Guarda; Rayra Pereira Santiago; Bruna Laís Almeida Cunha; Camylla Villas Boas Figueiredo; Sânzio Silva Santana; Silvana Sousa da Paz; Júnia Raquel Dutra Ferreira; Bruno Antônio Veloso Cerqueira; Marilda de Souza Gonçalves
Journal:  BMC Hematol       Date:  2017-09-15

9.  Potential therapeutic action of nitrite in sickle cell disease.

Authors:  Nadeem Wajih; Swati Basu; Anuj Jailwala; Hee Won Kim; David Ostrowski; Andreas Perlegas; Crystal A Bolden; Nancy L Buechler; Mark T Gladwin; David L Caudell; Elaheh Rahbar; Martha A Alexander-Miller; Vidula Vachharajani; Daniel B Kim-Shapiro
Journal:  Redox Biol       Date:  2017-05-10       Impact factor: 11.799

10.  On the Effects of Reactive Oxygen Species and Nitric Oxide on Red Blood Cell Deformability.

Authors:  Lukas Diederich; Tatsiana Suvorava; Roberto Sansone; T C Stevenson Keller; Frederik Barbarino; Thomas R Sutton; Christian M Kramer; Wiebke Lückstädt; Brant E Isakson; Holger Gohlke; Martin Feelisch; Malte Kelm; Miriam M Cortese-Krott
Journal:  Front Physiol       Date:  2018-05-11       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.